Development of a functional composite for the evaluation of spinal and bulbar muscular atrophy

被引:2
|
作者
Inagaki, Tomonori [1 ]
Hashizume, Atsushi [1 ,2 ]
Hijikata, Yasuhiro [1 ]
Yamada, Shinichiro [1 ]
Ito, Daisuke [1 ]
Kishimoto, Yoshiyuki [1 ]
Torii, Ryota [1 ]
Sato, Hiroyuki [3 ]
Hirakawa, Akihiro [3 ]
Katsuno, Masahisa [1 ,2 ]
机构
[1] Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Dept Clin Res Educ, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan
[3] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Clin Biostat, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan
关键词
ANDROGEN RECEPTOR; OUTCOME MEASURES; NATURAL-HISTORY; DISEASE; BIOMARKER; THERAPEUTICS; PERFORMANCE; LEUPRORELIN; MODELS; ATAXIA;
D O I
10.1038/s41598-022-22322-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study aimed to develop a functional measurement that combines quantitative motor evaluation index of various body regions in patients with spinal and bulbar muscular atrophy (SBMA). We assessed subjects with SBMA and healthy controls with quantitative muscle strength measurements and functional scales. We selected tongue pressure, grip power, % peak expiratory flow (%PEF), timed walking test, and % forced vital capacity (%FVC) as components. By combining these values with Z-score, we created a functional composite (SBMA functional composite: SBMAFC). We also calculated the standardized response mean to compare the sensitivity of SBMAFC with that of existing measurements. A total of 97 genetically confirmed patients with SBMA and 36 age- and sex-matched healthy controls were enrolled. In the longitudinal analysis, the standardized response mean of SBMAFC was larger than that of existing rating scales. Receiver operating characteristic (ROC) analysis demonstrated that the SBMAFC is capable of distinguishing between subjects with early-stage SBMA and healthy controls. SBMAFC is more sensitive to disease progression than existing functional rating scales and is a potential outcome measure in clinical trials of SBMA.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Spinal and Bulbar Muscular Atrophy Overview
    Fischbeck, Kenneth H.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 58 (03) : 317 - 320
  • [2] Developing treatment for spinal and bulbar muscular atrophy
    Fischbeck, Kenneth H.
    PROGRESS IN NEUROBIOLOGY, 2012, 99 (03) : 257 - 261
  • [3] Swallowing markers in spinal and bulbar muscular atrophy
    Banno, Haruhiko
    Katsuno, Masahisa
    Suzuki, Keisuke
    Tanaka, Seiya
    Suga, Noriaki
    Hashizume, Atsushi
    Mano, Tomoo
    Araki, Amane
    Watanabe, Hirohisa
    Fujimoto, Yasushi
    Yamamoto, Masahiko
    Sobue, Gen
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (08): : 534 - 543
  • [4] Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy
    Hashizume, Atsushi
    Katsuno, Masahisa
    Banno, Haruhiko
    Suzuki, Keisuke
    Suga, Noriaki
    Mano, Tomoo
    Atsuta, Naoki
    Oe, Hiroaki
    Watanabe, Hirohisa
    Tanaka, Fumiaki
    Sobue, Gen
    BRAIN, 2012, 135 : 2838 - 2848
  • [5] Progress toward the development of treatment of spinal and bulbar muscular atrophy
    Sahashi, Kentaro
    Hashizume, Atsushi
    Sobue, Gen
    Katsuno, Masahisa
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (06): : 503 - 514
  • [6] Molecular diagnosis of spinal and bulbar muscular atrophy in Slovakia
    Zelinkova, H.
    Kolejakova, Lexova K.
    Spalek, P.
    Chandoga, J.
    Konkolova, J.
    Bohmer, D.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (03): : 137 - 141
  • [7] Spinal and Bulbar Muscular Atrophy
    Grunseich, Christopher
    Fischbeck, Kenneth H.
    NEUROLOGIC CLINICS, 2015, 33 (04) : 847 - +
  • [8] No evidence of cardiomyopathy in spinal and bulbar muscular atrophy
    Querin, G.
    Melacini, P.
    D'Ascenzo, C.
    Morandi, L.
    Mazzini, L.
    Silani, V.
    Romito, S.
    Mandrioli, J.
    Raimondi, M.
    Pegoraro, E.
    Soraru', G.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (06): : E30 - E32
  • [9] Dutasteride for spinal and bulbar muscular atrophy
    Banno, Haruhiko
    Katsuno, Masahisa
    Suzuki, Keisuke
    Sobue, Gen
    LANCET NEUROLOGY, 2011, 10 (02) : 113 - 115
  • [10] EVALUATION OF SPINAL AND BULBAR MUSCULAR ATROPHY BY THE CLUSTERING INDEX METHOD
    Higashihara, Mana
    Sonoo, Masahiro
    Yamamoto, Tomotaka
    Nagashima, Yu
    Uesugi, Haruo
    Terao, Yasuo
    Ugawa, Yoshikazu
    Stalberg, Erik
    Tsuji, Shoji
    MUSCLE & NERVE, 2011, 44 (04) : 539 - 546